Client Resource, Health Markers
Simple, free, and more predictive of cardiovascular and metabolic risk than BMI. Most people have never calculated theirs.
BMI (body mass index) is the most widely used body composition metric in clinical practice. It is also one of the weakest. BMI does not distinguish between muscle and fat, does not capture where fat is distributed in the body, and consistently misclassifies lean muscular individuals (as overweight) and metabolically unhealthy normal-weight individuals (as healthy).
Waist-to-height ratio (WtHR) addresses the most important limitation of BMI: it captures central adiposity, fat distribution around the abdomen and visceral organs, which is the biologically active location where excess fat drives metabolic and cardiovascular disease. Visceral fat produces inflammatory cytokines, impairs insulin signalling, and is directly associated with cardiovascular disease, type 2 diabetes, and all-cause mortality independently of total body weight.
A systematic review and meta-analysis of 31 studies found WtHR was a significantly better predictor of cardiovascular risk, diabetes, hypertension, and metabolic syndrome than BMI in both men and women. A simple threshold of 0.5 correctly identified at-risk individuals across diverse populations. (Ashwell et al., Obes Rev 2012)
Measure your waist circumference at the navel, relaxed, at the end of a normal exhalation. Measure your height. Divide waist by height. Both in centimetres or both in inches. The result is a dimensionless ratio. Below 0.5 is the general healthy threshold across most populations. Between 0.5 and 0.6 is elevated risk. Above 0.6 is high risk. Example: 90cm waist, 180cm height = 90/180 = 0.50. At the boundary. At 94cm waist: 94/180 = 0.52, elevated risk zone.
Measurement tip: Measure at the natural waist or navel level without clothing, after a normal exhalation. Consistency in your own repeated measurements matters most. Same time of day, same conditions.
Two people can have identical BMI but radically different cardiometabolic risk profiles depending on whether their excess weight is subcutaneous (metabolically relatively inert) or visceral (metabolically active and directly pathological). WtHR captures the abdominal component BMI misses. The Ashwell et al. systematic review of 31 studies found WtHR consistently outperformed BMI as a predictor of diabetes, hypertension, and cardiovascular disease. Approximately 20–30% of people with normal BMI have excess visceral fat and elevated metabolic risk. BMI misses all of them; WtHR catches most.
For training adults: People who resistance train often have higher BMI due to muscle mass but low WtHR due to low visceral fat. For this group WtHR is considerably more informative than BMI.
Multiple large prospective studies confirm WtHR as an independent predictor of cardiovascular events, cardiovascular mortality, and all-cause mortality after adjusting for traditional risk factors including BMI, cholesterol, blood pressure, and smoking. The risk relationship is continuous, increasing progressively above the 0.5 threshold, with no sharp step. Every 0.05-unit increase in WtHR above 0.5 is associated with meaningful incremental cardiovascular risk.
Compared to waist circumference alone: WtHR is adjusted for height, removing the confounding effect of body stature. A 90cm waist carries different risk in a 160cm person than in a 190cm person; WtHR accounts for this; raw waist circumference does not.
Visceral adiposity drives insulin resistance through multiple mechanisms: visceral fat releases free fatty acids and inflammatory cytokines (TNF-alpha, IL-6, resistin) that impair insulin receptor signalling in the liver and skeletal muscle. A WtHR above 0.5 substantially increases the probability of impaired glucose regulation and metabolic syndrome. Conversely, reductions in WtHR through diet and exercise directly improve insulin sensitivity, often before any change in blood glucose is detectable.
Targets for metabolic health: Moving WtHR from above 0.55 to below 0.5 consistently produces meaningful improvements in metabolic markers within 3–6 months of appropriate intervention combining resistance training, adequate protein, and modest calorie deficit.
Bodyweight on a scale conflates muscle gain, fat loss, water retention, and glycogen storage. A person who gains 2kg of muscle and loses 2kg of fat has a net weight change of zero but dramatically improved health and body composition. Waist circumference changes specifically in response to visceral fat reduction, which is what matters for health outcomes. If you are resistance training and eating adequately, bodyweight may increase while waist circumference decreases, reflecting a genuinely improving trajectory that the scale misrepresents.
Monitoring frequency: Weekly or bi-weekly measurement is sufficient. Day-to-day variation due to hydration and digestion makes daily tracking unreliable. Track the trend over months, not the noise week to week.
The public health message from WtHR research is unusually simple: keep your waist circumference to less than half your height. This rule, proposed by Ashwell and Hsieh and validated across multiple populations and ethnicities, correctly identifies individuals at elevated cardiometabolic risk with reasonable sensitivity and specificity across diverse age groups and body types. Some refinement by age applies: below 0.5 for adults under 50; below 0.53 may be a more realistic target for adults over 50. These thresholds are broadly applicable without age, sex, or ethnicity adjustment in the same way BMI reference ranges require.
The message: 0.5 is the target. Calculate yours now. If it is above 0.5, adequate protein, progressive resistance training, and a modest calorie deficit sustained over time is the most reliable pathway to getting below it.
Waist circumference is one of several body composition and health marker measurements taken during The Benchmark. WtHR, waist-to-hip ratio, and waist-to-height data are included in the Complete Picture section of the Benchmark report, contextualised against population norms and interpreted alongside the four performance pillars. Body composition markers are logged as contextual information rather than scored, because changes over time with training and nutrition are more meaningful than any single measurement.
Benchmark protocol: Waist and hip circumferences measured with a non-stretch tape. WtHR and waist-to-hip ratio calculated and recorded. Combined with Omron Karada BIA for body fat context.
Take a tape measure. Measure your waist at the navel. Divide by your height. If the result is above 0.5, you have a modifiable cardiovascular and metabolic risk factor that training, nutrition, and time can address. This number is more predictive of long-term cardiovascular risk than BMI, and it is free to measure.
The intervention is not complicated: adequate protein, consistent resistance training, a modest calorie deficit if needed, sustained over time. The WtHR follows. Tracking it monthly alongside performance metrics gives a measurable picture of the direction your health is moving.
Book The Benchmark →Ashwell M, Gunn P, Gibson S, Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: a systematic review and meta-analysis. Obes Rev 2012;13(3):275–286. 31 studies. Primary comparison of WtHR vs BMI.
Lee CMY et al., Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI. Eur Heart J 2008;29(2):233–240. Cardiovascular discrimination comparison.
Ashwell M, Hsieh SD, Six reasons why waist-to-height ratio is a rapid and effective global indicator for health risks of obesity. Int J Food Sci Nutr 2005;56(5):303–307. The 0.5 rule rationale.
Schneider HJ et al., The predictive value of different measures of obesity for incident cardiovascular events and mortality. J Clin Endocrinol Metab 2010;95(4):1777–1785. Independent mortality prediction confirmed.
Browning LM et al., A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes. Nutr Res Rev 2010;23(2):247–269. Metabolic disease prediction evidence.